☰

Rebecca Foster - Publications

Affiliations: 
2001-2004 School of Clinical Sciences University of Bristol, Bristol, England, United Kingdom 
Tree Info Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Fawaz S, Martin Alonso A, Qiu Y, Ramnath R, Stowell-Connolly H, Gamez M, May C, Down C, Coward RJ, Butler MJ, Welsh GI, Satchell SC, Foster RR. Adiponectin reduces glomerular endothelial glycocalyx disruption and restores glomerular barrier function in a mouse model of type 2 diabetes. Diabetes. PMID 38530908 DOI: 10.2337/db23-0455  0.452
2024 Gamez M, Elhegni HE, Fawaz S, Ho KH, Campbell NW, Copland DA, Onions KL, Butler MJ, Wasson EJ, Crompton M, Ramnath RD, Qiu Y, Yamaguchi Y, Arkill KP, Bates DO, ... ... Foster RR, et al. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes. Cardiovascular Diabetology. 23: 50. PMID 38302978 DOI: 10.1186/s12933-024-02133-1  0.81
2023 Finch NC, Neal CR, Welsh GI, Foster RR, Satchell SC. The unique structural and functional characteristics of glomerular endothelial cell fenestrations and their potential as a therapeutic target in kidney disease. American Journal of Physiology. Renal Physiology. PMID 37471420 DOI: 10.1152/ajprenal.00036.2023  0.326
2023 Crompton M, Ferguson JK, Ramnath R, Onions KL, Ogier AS, Gamez M, Down CJ, Skinner LJ, Wong KH, Dixon LK, Sutak J, Harper SJ, Pontrelli P, Gesualdo L, Heerspink HL, ... ... Foster RR, et al. Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx. Jci Insight. PMID 36749631 DOI: 10.1172/jci.insight.154164  0.786
2022 Lawrence-Mills SJ, Hughes D, Hezzell MJ, Butler M, Neal C, Foster RR, Welsh GI, Finch N. The Microvascular Endothelial Glycocalyx: An Additional Piece of the Puzzle in Veterinary Medicine. Veterinary Journal (London, England : 1997). 105843. PMID 35654338 DOI: 10.1016/j.tvjl.2022.105843  0.317
2022 Finch N, Fawaz S, Neal C, Butler M, Lee V, Salmon A, Lay A, Stevens M, Dalayan L, Band H, Mellor H, Harper S, Shima D, Welsh G, Foster R, et al. Reduced Glomerular Filtration in Diabetes is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell Fenestrations. Journal of the American Society of Nephrology : Jasn. PMID 35292439 DOI: 10.1681/ASN.2021030294  0.792
2022 Qiu Y, Buffonge S, Ramnath R, Jenner S, Fawaz S, Arkill KP, Neal C, Verkade P, White SJ, Hezzell M, Salmon AHJ, Suleiman MS, Welsh GI, Foster RR, Madeddu P, et al. Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice. Diabetologia. PMID 35211778 DOI: 10.1007/s00125-022-05650-4  0.378
2020 Butler MJ, Down CJ, Foster RR, Satchell SC. The pathological relevance of increased endothelial glycocalyx permeability. The American Journal of Pathology. PMID 32035881 DOI: 10.1016/j.ajpath.2019.11.015  0.424
2019 Ramnath RD, Butler MJ, Newman G, Desideri S, Russell A, Lay AC, Neal CR, Qiu Y, Fawaz S, Onions KL, Gamez M, Crompton M, Michie C, Finch N, Coward RJ, ... ... Foster RR, et al. Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease. Kidney International. PMID 32037077 DOI: 10.1016/J.Kint.2019.09.035  0.819
2019 Desideri S, Onions KL, Baker SL, Gamez M, El Hegni E Hussien H, Russel A, Satchell SC, Foster RR. Endothelial glycocalyx restoration by growth factors in diabetic nephropathy. Biorheology. PMID 31156139 DOI: 10.3233/Bir-180199  0.836
2019 Down CJ, Neal CR, Foster RR, Satchell SC, Bills VL. Quantifying placental endothelial and syncytiotrophoblast glycocalyx with lectin histochemistry Pregnancy Hypertension. 17: S12. DOI: 10.1016/J.Preghy.2019.08.111  0.83
2018 Fabre-Gray ACM, Down CJ, Neal CR, Foster RR, Satchell SC, Bills VL. Imaging the placental glycocalyx with transmission electron microscopy. Placenta. PMID 30616903 DOI: 10.1016/j.placenta.2018.12.004  0.752
2018 Onions K, Gamez M, Buckner NR, Baker SL, Betteridge KB, Desideri S, Dallyn BP, Ramnath R, Neal CR, Farmer LK, Mathieson PW, Gnudi L, Alitalo K, Bates DO, Salmon AHJ, ... ... Foster RR, et al. VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy. Diabetes. PMID 30389746 DOI: 10.2337/Db18-0045  0.823
2018 Butler MJ, Ramnath R, Kadoya H, Desposito D, Riquier-Brison A, Ferguson JK, Onions KL, Ogier AS, ElHegni H, Coward RJ, Welsh GI, Foster RR, Peti-Peterdi J, Satchell SC. Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx. Kidney International. PMID 30389198 DOI: 10.1016/J.Kint.2018.08.024  0.807
2018 Bates DO, Beazley-Long N, Benest AV, Ye X, Ved N, Hulse RP, Barratt S, Machado MJ, Donaldson LF, Harper SJ, Peiris-Pages M, Tortonese DJ, Oltean S, Foster RR. Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators. Comprehensive Physiology. 8: 955-979. PMID 29978898 DOI: 10.1002/Cphy.C170015  0.751
2018 Desideri S, Onions KL, Butler MJ, Michel CC, Satchell SC, Salmon AHJ, Foster RR. The Authors Reply. Kidney International. 94: 220. PMID 29933849 DOI: 10.1016/J.Kint.2018.04.013  0.716
2018 Desideri S, Onions KL, Qiu Y, Ramnath RD, Butler MJ, Neal CR, King MLR, Salmon AE, Saleem MA, Welsh GI, Michel CC, Satchell SC, Salmon AHJ, Foster RR. A novel assay provides sensitive measurement of physiologically relevant changes in albumin permeability in isolated human and rodent glomeruli. Kidney International. PMID 29433915 DOI: 10.1016/J.Kint.2017.12.003  0.789
2018 Down C, Neal C, Fabre-Gray A, Foster R, Satchell S, Bills V. 271 Imaging the placental glycocalyx Pregnancy Hypertension. 13: S115-S116. DOI: 10.1016/J.Preghy.2018.08.341  0.777
2015 Lobo DP, Wemyss AM, Smith DJ, Straube A, Betteridge KB, Salmon AH, Foster RR, Elhegni HE, Satchell SC, Little HA, Pacheco-Gómez R, Simmons MJ, Hicks MR, Bates DO, Rodger A, et al. Direct detection and measurement of wall shear stress using a filamentous bio-nanoparticle. Nano Research. 8: 3307-3315. PMID 27570611 DOI: 10.1007/S12274-015-0831-X  0.757
2014 Oltean S, Qiu Y, Ferguson JK, Stevens M, Neal C, Russell A, Kaura A, Arkill KP, Harris K, Symonds C, Lacey K, Wijeyaratne L, Gammons M, Wylie E, Hulse RP, ... ... Foster RR, et al. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy. Journal of the American Society of Nephrology : Jasn. PMID 25542969 DOI: 10.1681/Asn.2014040350  0.81
2014 Ramnath R, Foster RR, Qiu Y, Cope G, Butler MJ, Salmon AH, Mathieson PW, Coward RJ, Welsh GI, Satchell SC. Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α: a contributor to endothelial cell glycocalyx dysfunction. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 4686-99. PMID 25122554 DOI: 10.1096/Fj.14-252221  0.695
2014 Wylie E, Foster R, Salmon A, Satchell S. Role of the endothelial glycocalyx in kidney disease and vascular dysfunction The Lancet. 383. DOI: 10.1016/S0140-6736(14)60375-5  0.769
2013 Foster RR, Armstrong L, Baker S, Wong DW, Wylie EC, Ramnath R, Jenkins R, Singh A, Steadman R, Welsh GI, Mathieson PW, Satchell SC. Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro. The American Journal of Pathology. 183: 604-16. PMID 23770346 DOI: 10.1016/j.ajpath.2013.04.019  0.394
2013 Singh A, Ramnath RD, Foster RR, Wylie EC, Fridén V, Dasgupta I, Haraldsson B, Welsh GI, Mathieson PW, Satchell SC. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. Plos One. 8: e55852. PMID 23457483 DOI: 10.1371/journal.pone.0055852  0.353
2012 Wiggins C, Astley H, Mahoney C, Sorrell D, Torrance C, Foster R. Abstract 2137: Using Rac1 isogenic cells to model tumor metastasis Cancer Research. 72: 2137-2137. DOI: 10.1158/1538-7445.Am2012-2137  0.314
2011 Singh A, Fridén V, Dasgupta I, Foster RR, Welsh GI, Tooke JE, Haraldsson B, Mathieson PW, Satchell SC. High glucose causes dysfunction of the human glomerular endothelial glycocalyx. American Journal of Physiology. Renal Physiology. 300: F40-8. PMID 20980411 DOI: 10.1152/ajprenal.00103.2010  0.352
2010 Foster RR, Welsh GI, Satchell SC, Marlow RD, Wherlock MD, Pons D, Mathieson PW, Bates DO, Saleem MA. Functional distinctions in cytosolic calcium regulation between cells of the glomerular filtration barrier. Cell Calcium. 48: 44-53. PMID 20674014 DOI: 10.1016/J.Ceca.2010.06.005  0.428
2009 Foster RR. The importance of cellular VEGF bioactivity in the development of glomerular disease Nephron - Experimental Nephrology. 113. PMID 19590237 DOI: 10.1159/000228078  0.43
2009 Foster RR, Zadeh MA, Welsh GI, Satchell SC, Ye Y, Mathieson PW, Bates DO, Saleem MA. Flufenamic acid is a tool for investigating TRPC6-mediated calcium signalling in human conditionally immortalised podocytes and HEK293 cells. Cell Calcium. 45: 384-90. PMID 19232718 DOI: 10.1016/J.Ceca.2009.01.003  0.424
2008 Bevan HS, Van Den Akker NMS, Qiu Y, Polman JAE, Foster RR, Yem J, Nishikawa A, Satchell SC, Harper SJ, Gittenberger-De Groot AC, Bates DO. The alternatively spliced anti-angiogenic family of VEGF isoforms VEGF xxxb in human kidney development Nephron - Physiology. 110. PMID 19039247 DOI: 10.1159/000177614  0.828
2008 Foster RR, Slater SC, Seckley J, Kerjaschki D, Bates DO, Mathieson PW, Satchell SC. Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium American Journal of Pathology. 173: 938-948. PMID 18772335 DOI: 10.2353/Ajpath.2008.070416  0.636
2006 Cheng HW, James AF, Foster RR, Hancox JC, Bates DO. VEGF activates receptor-operated cation channels in human microvascular endothelial cells Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 1768-1776. PMID 16763162 DOI: 10.1161/01.Atv.0000231518.86795.0F  0.596
2006 Foster RR, Satchell SC, Seckley J, Emmett MS, Joory K, Xing CY, Saleem MA, Mathieson PW, Bates DO, Harper SJ. VEGF-C promotes survival in podocytes American Journal of Physiology - Renal Physiology. 291. PMID 16525158 DOI: 10.1152/Ajprenal.00431.2005  0.793
2005 Coward RJ, Foster RR, Patton D, Ni L, Lennon R, Bates DO, Harper SJ, Mathieson PW, Saleem MA. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes. Journal of the American Society of Nephrology : Jasn. 16: 629-37. PMID 15659563 DOI: 10.1681/Asn.2004030172  0.611
2005 Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes American Journal of Physiology - Renal Physiology. 288. PMID 15339792 DOI: 10.1152/Ajprenal.00146.2004  0.738
2004 Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, Shields JD, Whittles CE, Mushens RE, et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Research. 64: 7822-35. PMID 15520188 DOI: 10.1158/0008-5472.Can-04-0934  0.797
2004 Cui TG, Foster RR, Saleem M, Mathieson PW, Gillatt DA, Bates DO, Harper SJ. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein American Journal of Physiology - Renal Physiology. 286. PMID 14644752 DOI: 10.1152/Ajprenal.00337.2003  0.749
2004 Pocock TM, Foster RR, Bates DO. Evidence of a role for TRPC channels in VEGF-mediated increased vascular permeability in vivo American Journal of Physiology - Heart and Circulatory Physiology. 286. PMID 14551041 DOI: 10.1152/Ajpheart.00826.2003  0.609
2004 Foster RR, Mathieson PW, Saleem MA, Bates DO, Harper SJ. PC32 VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ACTS THROUGH NEPHRIN TO REDUCE APOPTOSIS IN HUMAN CONDITIONALLY IMMORTALISED PODOCYTES (HCIPS) Microcirculation. 11: 549-550. DOI: 10.1080/10739680490488715  0.748
2003 Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes American Journal of Physiology - Renal Physiology. 284. PMID 12620928 DOI: 10.1152/Ajprenal.00276.2002  0.716
Show low-probability matches.